Statement regarding IFFIm and Eurostat ruling

Statement Attributable to Julian Lob-Levyt, Executive Secretary, the Global Alliance for Vaccines and Immunization (GAVI) and CEO of The Vaccine Fund

Geneva, 2 August 2005 - The Eurostat decision paves the way for the full-funding and eventual implementation of IFFIm. We are delighted by this decision and are grateful to all those who worked so hard to create this innovative financing vehicle.

IFFIm funding will allow us to scale up immunization and introduce new vaccines to millions of the world's poorest children. With a fully funded IFFIm of USD $4 billion, an estimated 10 million premature deaths will be averted, health systems in 72 of the poorest countries will be strengthened, and much of the sickness and suffering that plagues so many of the world's families will be eliminated.

Scaling up immunization will also energize global efforts to reach the Millennium Development Goals (MDGs). Increasing the number of children who receive routine immunization will save millions of lives and will help the world meet the goal of improving child health (MDG-4).

We thank the UK , France and Sweden for their commitment to immunization and their vision in creating this innovative financing mechanism. We also thank the governments of Canada, Germany, Italy, Spain and others for their interest in this project and the people of all these countries for their generosity and willingness to invest in the future of the world's children. We look forward to working with them and with others as we redouble our efforts to ensure that the promise of the IFFIm is realized.

Français Español

US$ 1 = US$ 18

A study in Health Affairs covering 73 Gavi-supported countries over the 2011–2020 period shows that, for every US$ 1 spent on immunisation, US$ 18 are saved in healthcare costs, lost wages and lost productivity due to illness. If we take into account the broader benefits of people living longer, healthier lives, the return on investment rises to US$ 48 per US$ 1 spent.

Ozawa S, Clark S, Portnoy A et al. Return on investment from childhood immunizations in low- and middle-income countries, 2011-20, Health Affairs 2016.

More facts...

close icon

modal window here